Goldman Sachs just refreshed its conviction lists of global stocks — giving one 67% upside

Goldman Sachs just refreshed its lists of top global stock picks, adding some and removing others. The investment bank's "Conviction List - Directors' Cut" aims to offer investors a "curated and active" list of 15 to 25 buy-rated stocks. The stocks are selected by a subcommittee designated by the bank's Investment Review Committee for each region.

Samsung Biologics Goldman likes South Korean biotechnology company Samsung Biologics, which it says is "set to capitalize on growing demand for biologics CDMOs via its build-out of world-leading capacity." Other merits of the company include its "competitive pricing strategy," Goldman analyst Ziyi Chen wrote in a May 2 note on the bank's Asia-Pacific list.

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

10 things to watch in the stock market Monday: Goldman Sachs, Nvidia, Constellation BrandsThe market is trying to rebound from Friday's selloff on hopes that the conflict in the Middle East doesn't escalate further.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Goldman Sachs just updated its list of top global stocks, recommending a specific trading strategyGoldman Sachs has refreshed its conviction list of top stock picks across Europe and recommended investors consider a specific trading strategy.
ソース: CNBC - 🏆 12. / 72 続きを読む »

Stocks making the biggest moves midday: Tesla, Goldman Sachs, Salesforce and moreThese are some of the stocks posting the largest moves in midday trading.
ソース: CNBC - 🏆 12. / 72 続きを読む »